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Background: Cervicogenic dizziness is a disabling condition characterised by postural unsteadiness that is
aggravated by cervical spine movements and associated with a painful and/or stiff neck. Two manual therapy
treatments (Mulligan’s Sustained Natural Apophyseal Glides (SNAGs) and Maitland’s passive joint mobilisations) are
used by physiotherapists to treat this condition but there is little evidence from randomised controlled trials to
support their use. The aim of this study is to conduct a randomised controlled trial to compare these two forms of
manual therapy (Mulligan glides and Maitland mobilisations) to each other and to a placebo in reducing symptoms
of cervicogenic dizziness in the longer term and to conduct an economic evaluation of the interventions.
Methods: Participants with symptoms of dizziness described as imbalance, together with a painful and/or stiff neck
will be recruited via media releases, advertisements and mail-outs to medical practitioners in the Hunter region of
NSW, Australia. Potential participants will be screened by a physiotherapist and a neurologist to rule out other
causes of their dizziness. Once diagnosed with cervciogenic dizziness, 90 participants will be randomly allocated to
one of three groups: Maitland mobilisations plus range-of-motion exercises, Mulligan SNAGs plus self-SNAG
exercises or placebo. Participants will receive two to six treatments over six weeks. The trial will have unblinded
treatment but blinded outcome assessments. Assessments will occur at baseline, post-treatment, six weeks,
12 weeks, six months and 12 months post treatment. The primary outcome will be intensity of dizziness. Other
outcome measures will be frequency of dizziness, disability, intensity of cervical pain, cervical range of motion,
balance, head repositioning, adverse effects and treatment satisfaction. Economic outcomes will also be collected.
Discussion: This paper describes the methods for a randomised controlled trial to evaluate the effectiveness of
two manual therapy techniques in the treatment of people with cervicogenic dizziness for which there is limited
established evidence-based treatment.
Trial registration: ACTRN12611000073909Background
Dizziness is a very common condition in the community
that often leads to physical problems such as unsteadi-
ness and falls, as well as social, emotional and financial
issues [1]. There are many causes of dizziness, one being
a dysfunction in the upper cervical spine [1-4]. In this
condition, termed cervicogenic dizziness, the non-rotary
dizziness is described as imbalance or unsteadiness and
is related to movements or positions of the neck. Cervi-
cogenic dizziness is accompanied by a range of* Correspondence: Sue.Reid@newcastle.edu.au
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reproduction in any medium, provided the orsymptoms including neck pain, neck stiffness, headache,
and less often visual disturbances, nausea, ear fullness,
sweating, tinnitus, problems with swallowing, temporo-
mandibular joint pain, upper extremity radiculopathy,
general weakness and psychological symptoms such as
anxiety and disturbances in concentration and memory
[5]. Although a disabling condition, there is no estab-
lished treatment. There is some evidence for manual
therapy treatment of this condition but good quality ran-
domised controlled trials (RCTs) are scarce [3,6]. The
existence of cervicogenic dizziness has been a topic of
some controversy [7,8] but more recent studies andd. This is an Open Access article distributed under the terms of the Creative
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ence [4,9-16].
It has been suggested by Hulse [17] that one third of
people with cervical dizziness have their onset due to
trauma such as whiplash, one third have an insidious
onset following spinal degeneration, and one third are
due to other causes. Whiplash injuries are experienced
by 0.1% of the population [18] and the incidence of
symptoms of dizziness in whiplash sufferers has been
variously reported as 20-58% [19], 40-80% [20] and as
high as 80-90% [21-23].
Cervical spondylosis, where the cervical zygapophyseal
joints are under abnormal mechanical stress, is a major
cause of poor balance and dizziness associated with spinal
degeneration [19]. This may occur in people with vertebral
collapse, decreased cervical disc height or herniated discs,
degenerative lesions (e.g. osteoarthritis), inflammatory dis-
eases (e.g. rheumatoid arthritis), vertebral displacement,
muscle spasm, or in those wearing cervical collars
[19,24,25]. The cervical zygapophyseal joints are the most
densely innervated of all the spinal joints [26] with 50% of
all cervical proprioceptors occurring in the joint capsules
of C1 to C3 [17]. In a study by Colledge et al. [27] investi-
gating the causes of dizziness in the elderly, the authors
attributed dizziness to cervical spondylosis in 65% of cases.
In support of this theory, extensive degenerative changes
such as osteophytes and discopathy on cervical X-rays have
been reported in people with this problem [24,28,29]. It is
believed that dizziness can also be caused by dysfunction
of the deep muscular proprioceptors in the upper cervical
spine leading to abnormal input to the vestibular nuclei
[19]. In a study by Treleaven, Jull and Sterling in 2003,
people with whiplash-associated dizziness and/or unsteadi-
ness (n=102) were shown to have significantly greater joint
position errors and a higher neck pain index than control
subjects (n=44), consistent with cervical mechanoreceptor
dysfunction being a likely cause of the symptoms [30].
Manual therapy treatments
In 1991, Brian Mulligan, a New Zealand physiotherapist,
introduced a physical therapy treatment for cervicogenic
dizziness called Sustained Natural Apophyseal Glides
(SNAGs) [31]. Although this treatment is used clinically
and is accepted in the Physiotherapy profession, there has
been very little research to evaluate its efficacy for cervico-
genic dizziness. SNAGs have been shown to be an effective
treatment for this problem in the short term (12 weeks) [4],
however no longer term follow-up of this treatment has
been undertaken. Geoff Maitland described another form
of manual therapy called passive joint mobilisations that
are commonly used to treat neck pain, headaches and other
neck problems [32]. A systematic review of the literature
showed there is a lack of quality studies evaluating the
treatment of cervicogenic dizziness with manual therapyand no studies evaluating the efficacy of Maitland mobilisa-
tions in the treatment of this condition [3].
Study aims
The aim of this paper is to report the study protocol used
to investigate the effectiveness of two manual therapy
treatments in reducing the symptoms of cervicogenic
dizziness and associated pain over 12 months. This will
be investigated by comparing the effects of these treat-
ments to each other and to a placebo intervention. Other
aims of the study are: 1) to assess the effects of the inter-
ventions on cervical range of motion, head repositioning
and balance; 2) assess and compare the cost effectiveness
of the interventions; and 3) to report any possible adverse
effects and treatment satisfaction.
Methods/Design
A prospective RCT with unblinded treatment and blinded
outcome assessment will be conducted in the School of
Health Sciences at the University of Newcastle, Australia.
Participants (with cervicogenic dizziness) will be randomly
allocated to SNAGs, Maitland passive joint mobilisation
or placebo groups. Each participant will receive two to six
treatments by an experienced physiotherapist over six
weeks at the discretion of the treating therapist who will
use their clinical judgement to determine the specific
dosage based on the participant’s response. Treatment
will cease if the participant perceives the condition is
adequately improved or if the improvement plateaus,
that is, no further improvement is evident over three
successive visits.
Ethics approval
The study design and procedures were approved by the
University of Newcastle Human Research Ethics Com-
mittee (Protocol Number: H-2009-0377), and the proce-
dures followed were in accordance with the Helsinki
Declaration of 1975, as revised in 2000. Written
informed consent will be obtained from all participants
prior to enrolment in the study.
Participants and recruitment
Ninety participants with cervicogenic dizziness will be
recruited in the Hunter region of NSW, Australia, via
media releases and resulting radio interviews and news-
paper articles, by advertisements in local newspapers,
and by referral from medical practitioners including
neurologists (Figure 1 Flow chart). Inclusion and exclu-
sion criteria are summarised in Table 1.
Screening of potential participants for cervicogenic
dizziness
A three step process will be followed to identify people with
cervicogenic dizziness. Firstly, an initial phone screening
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Figure 1 Flow chart of the research protocol.
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tial participants are still thought to have cervicogenic dizzi-
ness after the phone discussion they will then be examined
physically by the physiotherapist. Thirdly, if not excluded
by the physiotherapist at that stage they will have a clinical
examination by a neurologist including peripheral vestibu-
lar function testing.
Phone screening
During the phone screening a history will be taken by
the physiotherapist to establish that the person does
have dizziness described as imbalance or unsteadiness.
If the person has any other types of dizziness such as
vertigo, migrainous vertigo, pre-syncope, signs and
symptoms of vertebral artery ischaemia (dysarthria,
drop attacks, facial paraesthesia, syncope), orthostatic
hypotension or psychogenic dizziness [33] they will be
excluded. If the dizziness is described as imbalance or
unsteadiness it must be established that the imbalance
is not due to another cause including musculoskeletal
problems, neuromuscular problems, and conditions
affecting the brain such as Parkinson’s disease, stroke,cerebellar ataxia, multiple sclerosis, Vitamin B12 defi-
ciency or alcoholism. Then it must be established that
there is a related history of neck pain and or/stiffness.
The unsteadiness or poor balance must also be exacer-
bated by cervical spine movements or positions to be
considered to be due to cervicogenic dizziness.
Physical assessment by a physiotherapist
Those who have passed through the phone screening
and are thought to have cervicogenic dizziness then
undergo a physical assessment by a physiotherapist. This
physical examination includes:
– The Dix-Hallpike manoeuvre performed to
determine whether the person has dysfunction of
the semi-circular canals [34]. In this test, the
participant sits on the examination table while the
clinician rotates the participant’s head to 45 degrees
then quickly lays the participant straight back so
that their head is extended below the horizontal.
The production of nystagmus indicates benign
paroxysmal positional vertigo.
Table 1 Inclusion and exclusion criteria
Inclusion criteria:
- has dizziness described as imbalance related to neck
movements or positions and a stiff and/or
painful neck
- has had the symptoms present for greater than
3 months
- 18-90 years old
Exclusion criteria:
Known conditions that would put them at risk of injury:
- inflammatory joint disease
- spinal cord pathology
- cervical spine infection
- bony disease or marked osteoporosis
- marked cervical spine disc protrusion
- cervical spine cancer
- acute nerve root symptoms (severe pain, weakness,
pins and needles or numbness in the arm or hand
for less than 6 weeks)
- recent fracture/dislocation of the neck (in the last
3 months)
- previous surgery to the upper cervical spine
People will also be excluded if they have the following:
- other types or causes of dizziness, such as vertigo,
light headedness, psychogenic dizziness,
vertebrobasilar insufficiency
- other causes of poor balance
- migraines
- physiotherapy or similar treatment to the neck
in the previous month
- current pregnancy
- compensable cases
- inability to speak or read English
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after rising to standing with a digital
sphygmomanometer. A normal blood pressure
response to positional change will indicate that
neurocardiogenic syncope is an unlikely cause of the
dizziness [33]. A drop in systolic blood pressure
of > 30mm Hg or a drop of 10mm Hg in diastolic
blood pressure is indicative of orthostatic
hypotension [33].
– Smooth visual pursuit movements assessed by the
ability to track a slowly moving object. The
examiner looks for asymmetry of eye movement
which may indicate a cerebellar lesion [33].
– The vestibulo-ocular reflex with the participant
sitting maintaining a gaze on a stationary target
and performing small oscillations of the head
side-to-side and up-and-down. Abnormal responses
such as an inability to maintain the gaze for 60seconds due to dizziness, blurry vision or double
vision may indicate peripheral or central nervous
system dysfunction [33].
– Cervical range of motion assessment to determine
whether the participant has a restriction of
movement which may indicate cervical spine
dysfunction consistent with cervicogenic dizziness
[5]. The participant is asked to move their neck into
flexion, extension, left rotation, right rotation, left
lateral flexion and right lateral flexion and report
any symptoms such as dizziness or pain.
– Palpation of the upper cervical spine (occiput to C3)
performed to identify any stiff and/or painful joints
which may indicate dysfunction in the upper
cervical spine [5].
– Decreased balance has been reported in people with
cervicogenic dizziness [6]. To assess balance,
participants will be asked to hold tandem stance for
30 seconds. Tandem stance is a clinical measure of
standing balance considered to assess postural
steadiness in a heel-to-toe position [34].
Examination by a neurologist
If the participant is not excluded after this preliminary
screening, they are further assessed by a neurologist to
exclude central nervous system, vestibular and other
non-cervical causes of the dizziness. This examination
will include tests for vestibulo-spinal function, the
vestibulo-ocular system, disequilibrium such as gait and
balance testing, a repeat of the Dix-Hallpike manoeuvre
and peripheral vestibular function testing.
Randomisation
Participants who were not excluded during the screening
process will be randomly allocated to one of three inter-
vention groups: placebo, Mulligan SNAGS and Maitland
mobilisations. An independent statistician will produce a
computer generated randomisation sequence which will
be placed in sequentially numbered opaque sealed envelopes.
The randomisation sequence will contain equal numbers
of participants in each group.
Interventions
A physiotherapist with post graduate qualifications and a
minimum of 20 years experience in the field of manual
therapy will perform all the interventions during the
study to all the participants.
Placebo
One group of participants will have a placebo interven-
tion consisting of infrared therapy laser which has been
deactivated by the manufacturer. A medical laser is com-
monly used by physiotherapists to treat musculoskeletal
symptoms [35]. To the participant, the placebo laser
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Meyer Medical Electronics, Mordialloc, Australia) will
appear to operate normally with a light flashing and a
beeping sound, but it will not produce any effective
emission. The deactivated laser, which has been shown
to have a very strong placebo effect [4,35], will be ap-
plied for two minutes to each of three sites on the
neck, with the pen at a distance of 0.5-1 cm from the
skin [35].Mulligan SNAGs
Another group of participants will receive SNAGs as
described by Mulligan [36]. The participant, in the sit-
ting position, is asked to move their head in the direc-
tion that particularly produces their symptoms. As the
participant moves their head, the physiotherapist gently
glides the C1 or C2 vertebra anteriorly and sustains
the glide through the movement. During the applica-
tion of the glide, the participant should stay symptom-
free and is instructed to stop moving if any dizziness
is produced. This movement is repeated six times at
the first treatment session as recommended by Mulli-
gan. At the subsequent treatment sessions provided no
dizziness is experienced the SNAG is performed ten
times and gentle over pressure can be applied. A sec-
ond SNAG in another implicated direction of move-
ment may be added to treatment. After the second
treatment the participant will be advised to do a self-
SNAG (six repetitions) as a home exercise once daily.
Written and pictorial instructions for the home exer-
cise will be provided. A second home treatment self-
SNAG may be added for another implicated movement
direction after the third treatment. The participant will
be asked to perform the home exercises once daily for
12 months.Maitland mobilisations
The physiotherapist will palpate the neck to find the
three most dysfunctional joints and then perform pas-
sive joint mobilisations to those joints (as described
by Maitland et al.) [32]. A passive joint mobilisation is
where the therapist uses their thumbs to rhythmically
apply pressure to a vertebra usually in a posterior to
anterior direction. It is usually applied three times for
30 seconds to dysfunctional joints or determined by
the clinical judgement of the physiotherapist [32].
After the second treatment the participant will be
advised to perform range of motion exercises into
flexion, extension, right rotation, left rotation, left lat-
eral flexion and right lateral flexion, three times in
each direction, once a day for 12 months. Written
and pictorial instructions for the exercises will be
provided.Outcome measures
Socio-demographic data will be collected at baseline
including the participant’s age, gender, and time since
commencement of dizziness. The primary and second-
ary outcomes will be measured at baseline, after the
last treatment, at six weeks, 12 weeks, six months
(questionnaires only), and one year after treatment is
completed. All follow-up assessments will be conducted
by researchers blinded to the participants’ group alloca-
tion. The researchers conducting the data entry process
will be blinded to group allocation.
Primary outcome
Severity of dizziness (an average level over the previous
week) will be measured with a 100 mm horizontal visual
analogue scale (VAS). The VAS has been used success-
fully to measure dizziness in other studies [4,37-39].
Secondary outcomes
1) Frequency of dizziness will be measured on a six-
point rating scale (0 = no dizziness, 1 = dizziness less
than once per month, 2 = 1–4 episodes of dizziness
per month, 3 = 1–4 episodes of dizziness per week,
4 = dizziness once daily, 5 = dizziness more than
once a day or constant). This scoring method has
been used by several researchers [4,8,37,38] to
measure frequency of dizziness.
2) Disability caused by dizziness will be measured with
the Dizziness Handicap Inventory (DHI). This is a
health status measure specifically designed to assess
dizziness. The DHI assesses the quality of life using
three subscales evaluating the impact of dizziness on
the functional, emotional and physical aspects of
everyday life [40]. The highest possible score is 100,
indicating maximum self-perceived handicap. The
DHI has been shown to be a highly reliable and
responsive tool [40-42].
3) Severity of neck pain (an average level over the
previous week) will be assessed with a 100 mm VAS.
There is much evidence supporting the high validity
of the VAS for measuring pain intensity [43-47].
4) Global perceived effect will be used to assess
satisfaction with treatment and measured by self-
assessment on a six-point scale (0 = no benefit,
1 = minimal benefit, 2 = some benefit, 3 = a lot of
benefit, 4 = great benefit, 5 = maximal benefit) as
used in other studies [4,48,49].
5) Posturography will be used to identify and quantify
disturbances in balance. Body sway will be measured
with a Chattecx Balance Dynamic System (Serial No
1001, Chattecx Corporation, the Chattanooga
Group, Tennessee). Recordings will be performed
during the following tasks.
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position with eyes open
 standing erect with the neck in the neutral
position with eyes closed
 standing erect with the neck extended
 standing erect with the neck in left rotation
 standing erect with the neck in right rotation
 standing on a moving platform.Posturography has been used in many studies to assess
people with dizziness and has been found to have good
correlations with the participant’s symptoms [4,6,8,37].
6) A Cervical Range of Motion (CROM) goniometer
(Performance Attainment Associates, 3550 Lahore
Rd, St Paul, MN), which has been shown to be a
reliable tool with good validity [50], will be used to
measure cervical spine movements. Active flexion,
extension, left and right rotation, and left and right
lateral flexion will be measured. Each movement will
be measured three times and the average taken.
7) Neck repositioning sense will be assessed with the
CROM device. This task tests the participant’s ability
to accurately reposition their head and neck. The
participant is first seated with their head in a neutral
position. They are then asked to close their eyes and
to move their head into rotation. At mid-range of
rotation, the participant will be asked to stop, hold
their head steady and think about their position. This
position is referred to as the ‘target position’. After 5
seconds, the participant returns to the starting
position and then attempts to find the target position
again at which point a reading is taken. The number
of degrees difference between the target position and
the attempt to find it are calculated. This is
performed three times for both right and left
rotation and the average taken for each direction of
rotation movement.
Information about adverse events will be collected by
the treating physiotherapist at each treatment session
and by the research assistant at each follow-up measure-
ment session using open-ended questions as per normal
clinical practice.
Participants will be given a diary and asked to log
medication use, visits to a medical practitioner, visits to
other health professionals, time off work, changes in so-
cial engagements and adherence to home exercises.
Data analysis
Sample size calculation
The sample size required is based on an analysis using inde-
pendent t-tests to test for differences between pairs of treat-
ment groups, with alpha set at 0.05. Three comparisons willbe made: the SNAG group compared to the placebo
group, the Maitland mobilisation group compared to the
placebo group and the SNAG group compared to the
Maitland mobilisation group. Sample size calculations
were based on a difference between the two groups that
would be clinically significant for the main outcome
measures, supported by the results of previous research
where applicable data existed, and clinical expectations
for those factors for which no previous data existed. This
was estimated by biostatisticians from the Centre for
Clinical Epidemiology and Biostatistics, The University of
Newcastle, using other studies with the DHI and VAS as
outcome measures [41,49,51,52]. The DHI was the pri-
mary outcome measure used for sample size calculations,
as it is a widely reported measure of self-perceived dis-
ability and effect of dizziness on function. It has been
shown to have strong validity and short-term test-retest
reliability and good internal consistency [53,54]. Visual
analogue scales have also been used in many studies to
measure pain and the main complaint [49] and been
shown to have high reliability and validity, and a calcula-
tion of sample size was also based on VAS data.
Assuming that the standard deviation of DHI scores
is 15, then 30 participants per group will give the
study 80% power to detect a difference of 11 units be-
tween groups for each comparison. Thirty participants
per group are also required based on a 0–10 VAS scale
(e.g. for dizziness), with a standard deviation of 2.4 and a
clinically significant difference of 2 units with a power of
80% and a 5% confidence level.
Statistical methods
Biostatisticians from the University of Newcastle will
guide and assist with the statistical analyses. Baseline
characteristics will be summarized per group using the
number of observations, mean, standard deviation, me-
dian, minimum and maximum for continuous measures
and number of observations and frequency for categor-
ical measures. Primary and secondary outcome measures
are either continuous or ordinal in nature and will be
analysed using generalized linear mixed models. As an
example, for the primary outcome measure of the DHI,
the outcome variable will be the DHI and the predictors
will be time, treatment group and an interaction term for
time by treatment group. The p-value for the interaction
term will indicate whether there is a statistically signifi-
cant difference in change in the DHI over time between
the groups. We will use the ‘gate keeper’ approach to take
account of the multiple testing and restrict the overall
type I error rate to 5%. This means that we will test the
SNAG intervention against the placebo first, then the
Maitland mobilisation against the placebo and if those
results are statistically significant at the 5% level we will
then test the SNAG against the Maitland intervention.
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be compared between treatment groups at each time
point using independent t-tests.Economic evaluation
The type of economic evaluation by a health economist
will depend on the results. It is possible that there will
be a difference in efficacy, so a cost effectiveness or cost-
utility analysis will be appropriate. If one intervention
were more effective and less expensive, an incremental
cost effectiveness (utility) ratio (ICER) would not need
to be calculated as it would be clear that the more ef-
fective intervention is preferred. If one intervention were
more effective and more expensive, then an ICER would
need to be calculated. If the results show that one inter-
vention is equally effective to the alternative(s), then a
cost-minimisation analysis is appropriate. In this case,
there is no difference in effectiveness so the economic
analysis would be a comparison of costs only; if one
intervention is cheaper, it is the preferred alternative.Controlling bias
To minimise bias randomisation, concealed allocation,
specific inclusion and exclusion criteria, blinded out-
come assessment, patient blinding, blind data analysis,
and intention to treat analysis have been used. It was
not possible to blind the physiotherapist performing the
interventions.Discussion
This paper outlines the rationale and design for a RCT
that compares the effectiveness and cost effectiveness of:
a) SNAGs to a placebo intervention
b)Maitland passive joint mobilisations to a placebo
intervention
c) SNAGs to Maitland passive joint mobilisations
in reducing symptoms of cervicogenic dizziness and
associated pain over 12 months. The value of this study
will be to determine which of two common manual ther-
apy treatments is most effective for this problem and
whether manual therapy is effective in the longer term
(up to one year). The study will contribute to evidence-
based manual therapy leading to improved clinical deci-
sion making in this field of clinical practice.
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